Can BPC-157 cause nausea?

This site's BPC-157 citations do not report nausea as a counted adverse event. The Phase 1 enema study in 32 healthy volunteers, as described in FDA's 2026 evaluation, reported headache and flatulence occurring similarly on placebo. The two-person intravenous pilot reported no adverse effects. The 53-patient ulcerative colitis trial counted withdrawals for worsening colitis, not a nausea table. Absence of a counted nausea rate is not proof that nobody feels sick. It is proof that this FAQ cannot publish one. This FAQ does not invent an adverse-event rate the citations do not contain. Full record at /compounds/bpc-157.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of healing and recovery peptides. BPC-157, TB-500, GHK-Cu, and the tissue repair family, including what actually has human data.